Evidence map›Paper›PMID 32984743›Full record

ArticleJournal of the Endocrine Society2020

Sudden Cardiac Arrest in a Patient With Myxedema Coma and COVID-19.

Neal M Dixit, Katie P Truong, Soniya V Rabadia, David Li, Pratyaksh K Srivastava, Tina Mosaferi, Marcella A Calfon Press, Ines Donangelo, Theodoros Kelesidis

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of the Endocrine Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Systematic review of COVID-19 and autoimmune thyroiditis.Travel medicine and infectious disease
    Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Thyroid dysfunction in COVID-19.Nature reviews. Endocrinology · 2024
    Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. COVID-19 and Thyroid Diseases: A Bidirectional Impact.Journal of the Endocrine Society · 2021
    Review
  15. Review
  16. Observational
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Neal M DixitDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.ORCID 0000-0003-1517-5682
Katie P TruongDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
Soniya V RabadiaDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
David LiDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
Pratyaksh K SrivastavaDivision of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, California.
Tina MosaferiDivision of Endocrinology, David Geffen School of Medicine at UCLA, Los Angeles, California.ORCID 0000-0002-7578-7720
Marcella A Calfon PressDivision of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, California.
Ines DonangeloDivision of Endocrinology, David Geffen School of Medicine at UCLA, Los Angeles, California.ORCID 0000-0001-7202-8430
Theodoros KelesidisDivision of Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles, California.
University of California, Los Angeles · US

Funding

Oxidized HDL in the intersection of HIV, immune activation and atherosclerosisK08AI108272 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KELESIDIS, THEODOROS · 2013 to 2017
$915k
NIAID NIH HHS K08 AI108272
6 · The paper itself

Abstract

SARS-CoV-2 infection is associated with significant lung and cardiac morbidity but there is a limited understanding of the endocrine manifestations of coronavirus disease 2019 (COVID-19). Although thyrotoxicosis due to subacute thyroiditis has been reported in COVID-19, it is unknown whether SARS-CoV-2 infection can also lead to decompensated hypothyroidism. We present the first case of myxedema coma (MC) in COVID-19 and we discuss how SARS-CoV-2 may have precipitated multiorgan damage and sudden cardiac arrest in our patient. A 69-year-old woman with a history of small cell lung cancer presented with hypothermia, hypotension, decreased respiratory rate, and a Glasgow Coma Scale score of 5. The patient was intubated and administered vasopressors. Laboratory investigation showed elevated thyrotropin, very low free thyroxine, elevated thyroid peroxidase antibody, and markedly elevated inflammatory markers. SARS-CoV-2 test was positive. Computed tomography showed pulmonary embolism and peripheral ground-glass opacities in the lungs. The patient was diagnosed with myxedema coma with concomitant COVID-19. While treatment with intravenous hydrocortisone and levothyroxine were begun the patient developed a junctional escape rhythm. Eight minutes later, the patient became pulseless and was eventually resuscitated. Echocardiogram following the arrest showed evidence of right heart dysfunction. She died 2 days later of multiorgan failure. This is the first report of SARS-CoV-2 infection with MC. Sudden cardiac arrest likely resulted from the presence of viral pneumonia, cardiac arrhythmia, pulmonary emboli, and MC-all of which were associated with the patient's SARS-CoV-2 infection.

Indexed as

CoronavirusCOVID-19hypothyroidismimmunotherapythyroid

Identifiers

PMID32984743
PMCPMC7499619
OpenAlexW3082513131

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.